Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.

× No keyword cloud information.

11 in total

1. Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors: Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal: Clin Gastroenterol Hepatol Date: 2011-02-26 Impact factor: 11.382

2. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use.

Authors: Bernhardt Sachs; Stefan Riegel; Jörg Seebeck; Rainer Beier; Dagmar Schichler; Antina Barger; Hans F Merk; Stephan Erdmann
Journal: Drug Saf Date: 2006 Impact factor: 5.606

Review 3. Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors: Hans H Liu
Journal: Drug Saf Date: 2010-05-01 Impact factor: 5.606

4. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

Authors: Francesco Lapi; Marco Tuccori; Domenico Motola; Alessandra Pugi; Michele Vietri; Nicola Montanaro; Alberto Vaccheri; Olivia Leoni; Alfredo Cocci; Roberto Leone; Anita Conforti; Ugo Moretti; Emiliano Sessa; Giampiero Mazzaglia; Alessandro Mugelli; Teresita Mazzei; Alfredo Vannacci
Journal: Drug Saf Date: 2010-09-01 Impact factor: 5.606

Review 5. A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.

Authors: Yinhong Zhang; Xiaoyan Wang; Yang Cheng; Xiaofang Wang; Yunjian Zhang
Journal: BMC Pulm Med Date: 2022-07-19 Impact factor: 3.320

Review 6. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors: Françoise Van Bambeke; Paul M Tulkens
Journal: Drug Saf Date: 2009 Impact factor: 5.606

Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.

1. Clinical and histopathologic features of fluoroquinolone-induced liver injury.

2. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use.

Review 3. Safety profile of the fluoroquinolones: focus on levofloxacin.

4. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

Review 5. A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.

Review 6. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Review 7. Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Review 8. Hepatic safety of antibiotics used in primary care.

9. Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report.

10. Moxifloxacin in the treatment of skin and skin structure infections.